EUVIMEDEUVIMED entdecken
Crossref

Patterns and Predictors of Relapse Following Cytoreductive Surgery for Pseudomyxoma Peritonei

Mufaddal Kazi iD, Kaliki Sailesh Reddy iD, Ankit Sharma iD, Ashwin De Souza iD, Avanish Saklani iD

Journal of Surgical Oncology · 29.10.2026

DOI: 10.1002/jso.70445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 29.10.2026. Verfasst von Mufaddal Kazi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Advanced Centre for Treatment, Research, and Education in Cancer, ACTREC, Mumbai, Maharashtra, India. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the incidence, timing and anatomical pattern of relapse after cytoreductive surgery (CRS) for pseudomyxoma peritonei (PMP), and identify predictors of overall and early (within 12 months) relapse.

Methods

Retrospective cohort study of consecutive patients undergoing curative‐intent CRS for appendiceal PMP at a single institution (2016–2025), recording the site of first relapse. Predictors of progression‐free survival (PFS) and early relapse were evaluated using Cox and logistic regression.

Results

Among 204 patients, CC‐0/1 cytoreduction was achieved in 89% and HIPEC in 92%. At 37.1‐month median follow‐up, 89 patients (44%) relapsed; 3‐year PFS and overall survival were 50.2% and 75.6%. Relapse was predominantly intraperitoneal, most often the pelvis and small bowel/mesentery (25% each). Histology and completeness of cytoreduction independently predicted PFS: low‐grade (HR 2.18), high‐grade (HR 2.79) and signet‐ring PMP (HR 4.35) vs acellular mucin, CC‐2/3 (HR 2.18), and male sex (HR 1.74). Early relapse occurred in 34 patients (17%), independently predicted by high‐grade histology (OR 5.06) and CC‐2/3 (OR 3.55).

Conclusion

Relapse after CRS for PMP is predominantly intraperitoneal, most often the small bowel/mesentery and pelvis. Histology and completeness of cytoreduction are the principal determinants of overall and early relapse, supporting risk‐stratified surveillance and selective repeat cytoreduction.

Autor:innen und Institutionen

  • Department of Surgical Oncology, Advanced Centre for Treatment, Research, and Education in Cancer, ACTREC, Mumbai, Maharashtra, India.
  • Department of Surgical Oncology, Tata Memorial Hospital, Dr. E Borges Road, Mumbai, Maharashtra, India.

ORCID-Profile: Mufaddal Kazi, Kaliki Sailesh Reddy, Ankit Sharma, Ashwin De Souza, Avanish Saklani

Zitieren

APA

Kazi, M., Reddy, K. S., Sharma, A., De Souza, A., & Saklani, A. (2026). Patterns and Predictors of Relapse Following Cytoreductive Surgery for Pseudomyxoma Peritonei. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70445

Vancouver

Kazi M, Reddy KS, Sharma A, De Souza A, Saklani A. Patterns and Predictors of Relapse Following Cytoreductive Surgery for Pseudomyxoma Peritonei. Journal of Surgical Oncology. 2026. doi:10.1002/jso.70445

BibTeX
@article{Kazi2026,
  author = {Kazi, Mufaddal and Reddy, Kaliki Sailesh and Sharma, Ankit and De Souza, Ashwin and Saklani, Avanish},
  title = {Patterns and Predictors of Relapse Following Cytoreductive Surgery for Pseudomyxoma Peritonei},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  doi = {10.1002/jso.70445}
}
Kostenlos starten →